Sanjeev Luther

President, Chief Executive Officer and Chairman of the Board
Cornerstone Pharmaceuticals


Sanjeev Luther is credited with significant growth and performance in domestic and international markets. Strategic, pragmatic and results-driven, Sanjeev has led successful business-building and fundraising strategies and increased ROI for both Fortune 500 corporations and startups in pharmaceuticals, biotech, medical devices and diagnostics, including Bristol-Myers Squibb, Novartis, Bausch and Lomb, GE Healthcare and Mallinckrodt. He has a proven track record in driving productivity and reducing costs, with expertise across a range of therapeutic areas and stages, from R&D through commercialization.

At Cornerstone, Sanjeev advanced from CBO to COO, and then to his current role as CEO, in which he leads all of the company’s research and development initiatives, as well as all clinical trial programs. He is also a board member at Lipomedix.